Viral Hepatitis News

Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

People with hepatitis C, either treated or untreated, had an increased risk for developing active tuberculosis, according to data published in Clinical Infectious Diseases.

Despite indications for PrEP being prevalent among people with hepatitis C, most patients were unaware of PrEP, had never been offered PrEP and were not using PrEP, researchers found.

The use of oral tenofovir-based PrEP for HIV prevention in hepatitis B-endemic countries and in high-risk populations could “markedly decrease” the number of HIV and HBV coinfections, researchers found in a review.

New data from a CDC Vital Signs report show that less than one-third of people with hepatitis C receive treatment within 1 year of their diagnosis despite the availability of direct-acting antivirals.